Home
Scott Bizily, Chief Legal Officer: 4D Molecular Therapeutics FDMT Sell · Filed 24/02/21
Trade details
- Type
- Insider sale
- Amount
- $48,422.5
- Shares · price
- 1,750 sh · $27.67 a share
- Held after
- 1,737 sh
- Trade date
- 24/02/16
- Filed
- 24/02/21
- Days to filing
- 5 days
Sold 50.2% of holdings
- Share of holding sold
- 50.2%
4D Molecular Therapeutics trades, last 26 weeks
What else happened in 4D Molecular Therapeutics around then
Filed or reported within 30 days of the trade day · 24/01/17~24/03/17Scott Bizily's recent trades
- Scott Bizily
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan4D Molecular Therapeutics
FDMT
$79.7K
6,540 sh
$79.7K
Filed 08/17
Traded 08/17
- Scott Bizily
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan4D Molecular Therapeutics
FDMT
$19.4K
1,635 sh
$19.4K
Filed 08/13
Traded 08/13
- Scott Bizily
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan4D Molecular Therapeutics
FDMT
$84.6K
6,566 sh
$84.6K
Filed 06/30
Traded 06/30
- Scott Bizily
Sell10b5-1 plan4D Molecular Therapeutics
Sell10b5-1 plan4D Molecular Therapeutics
FDMT
$117.7K
9,810 sh
$117.7K
Filed 06/25
Traded 06/23
- Scott Bizily
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan4D Molecular Therapeutics
FDMT
$102.2K
9,810 sh
$102.2K
Filed 06/23
Traded 06/23